Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.


Methods used in the diagnosis of hematological malignancies are constantly evolving, with novel technologies being developed, and an increased importance being placed on earlier diagnosis, patient risk stratification, and genomic testing. Discover the latest in the field in several disease areas, including multiple myeloma, CLL, AML, ALL, and lymphoma.